Atlantic Honda Promotes Redesigned 2021 Honda Ridgeline Unibody Pickup Truck Now in Stock

LONG ISLAND, N.Y., Feb. 23, 2021 /PRNewswire-PRWeb/ — The 2021 Honda Ridgeline unibody pickup truck was recently released as a complete redesign over its previous model year. Changes present in the 2021 Honda Ridgeline over its previous iteration are extensive, including a new exterior and interior style and materials, upgraded performance features and newly available editions and packages. Drivers in the Long Island area can now test drive and buy the redesigned 2021…

LONG ISLAND, N.Y., Feb. 23, 2021 /PRNewswire-PRWeb/ — The 2021 Honda Ridgeline unibody pickup truck was recently released as a complete redesign over its previous model year. Changes present in the 2021 Honda Ridgeline over its previous iteration are extensive, including a new exterior and interior style and materials, upgraded performance features and newly available editions and packages. Drivers in the Long Island area can now test drive and buy the redesigned 2021 Honda Ridgeline model as it is now available for financing and leasing at the Atlantic Honda dealership in Bay Shore, New York.

The 2021 Honda Ridgeline model is equipped with a 3.5L inline 4 engine that is rated at 280 horsepower and 262 pound-foots of torque. This provides the 2021 Honda Ridgeline with a maximum towing capacity of 5,000 pounds. This engine option is paired with a 9-speed automatic transmission and standard all-wheel drive.

Additional feature highlights of the 2021 Honda Ridgeline include the dual-action tailgate with an In-Bed Trunk®, the Honda Satellite-Linked Navigation System™, Honda Sensing® safety technologies, an Intelligent Traction Dynamics System, a truck-bed audio system and twin exhaust outlets.

The current 2021 Honda Ridgeline model available in the Atlantic Honda vehicle inventory is the 2021 Honda Ridgeline Sport trim with the brand-new Radiant Red Metallic II paint color option. The Atlantic Honda dealership expects to have more 2021 Honda Ridgeline models in stock over the coming weeks.

For additional information on the redesigned 2021 Honda Ridgeline unibody pickup truck model, interested car shoppers and drivers in the Long Island area are encouraged to contact the staff at Atlantic Honda. The dealership team can be reached at 631-665-0005. Additional means of communication include online messages, emails and in-person visits to the store. The Atlantic Honda dealership is located at 1375 Sunshine Hwy., Bay Shore, New York 11706.

Media Contact

Sarah Strauch, Atlantic Honda, 631-328-2060, sstrauch@aagny.net

 

SOURCE Atlantic Honda

Green Burial is a Sustainable Solution for Overwhelmed Mortuaries

LINCOLN, Calif., Feb. 23, 2021 /PRNewswire/ — Green burial has long been a popular alternative to conventional burial. With COVID-19 taking an additional toll on traditional funeral homes, Morgan Oaks Eternal Preserve’s green burial services are a way to reduce the impact on morgues, funeral homes and the environment while honoring a loved one’s memory in a beautiful, natural setting.

<p title="Green Burials…

LINCOLN, Calif., Feb. 23, 2021 /PRNewswire/ — Green burial has long been a popular alternative to conventional burial. With COVID-19 taking an additional toll on traditional funeral homes, Morgan Oaks Eternal Preserve’s green burial services are a way to reduce the impact on morgues, funeral homes and the environment while honoring a loved one’s memory in a beautiful, natural setting.

COVID-19 has taken a toll on everyone, but the unprecedented death rate is weighing on funeral service practitioners. Hospitals bear the initial brunt of the crisis, but what happens when morgues and funeral homes are at their limits?

«Although many people turn to our service because it is a more environmentally friendly option, we’re seeing increased interest because of the process’s simplicity,» says Mark Heintz, founder of Morgan Oaks. «COVID has changed the way funerals and cremations are happening. By nature, our services are easily scaled so family and friends can say goodbye in a socially distanced and still respectful way.»

Morgan Oaks provides services that can help take some of the burden off other funeral businesses. The process allows bodies to return to the earth without the use of chemical preservatives or potential pollutants like caskets and grave liners. Green burial services include full-body interment, cremation remains burial, remains scattering and memorial trees on their 160-acre preserve and are compatible with virtually any type of funeral service – religious or secular.

«Whatever you think is the best way to honor your loved one’s legacy, we can help accommodate that,» Heintz said.

Through restorative, conservation-minded land management techniques aimed at maintaining a natural landscape preserved in perpetuity, choosing green burial contributes to the protection of natural areas while providing a meaningful place of remembrance. Morgan Oaks can also offer assistance for transporting remains.

For more information, visit https://www.morganoaksgreenburial.com.

Founded in 2020, Morgan Oaks Eternal Preserve provides families with natural and meaningful memorial landscapes that focus on preservation and stewardship. It is dedicated to creating beautiful and peaceful final resting spaces that are focused on restoring and protecting the natural surroundings of the existing ecosystems. They have a caring staff to guide you every step of the way as you navigate through difficult times. By choosing a green burial, you are not only choosing a more cost-effective option over traditional methods, but you will also be creating a long-lasting, living legacy.  For more information visit www.morganoaksgreenburial.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/green-burial-is-a-sustainable-solution-for-overwhelmed-mortuaries-301233197.html

SOURCE Morgan Oaks Eternal Preserve

TerraScale Wins Platinum 2020 Outstanding Property Award London In Property Design

RENO, Nev., Feb. 23, 2021 /PRNewswire/ — TerraScale, a clean infrastructure design and development firm committed to developing digital infrastructure around the world, together with Joe MacDonald, founding principal of <a target="_blank"…

RENO, Nev., Feb. 23, 2021 /PRNewswire/ — TerraScale, a clean infrastructure design and development firm committed to developing digital infrastructure around the world, together with Joe MacDonald, founding principal of Urban A&O, has been awarded a Platinum Outstanding Property Award London (OPAL) in the Category of Property Development – Environmental/Sustainability, for the conceptual design of TerraScale’s Energos Reno project.

OPAL recognizes the «best Architecture, Interior Design and Property Development projects from around the world,» with projects awarded based on their «creativity, innovation, social impact and sustainability.» The 2020 OPAL Platinum Award recognizes TerraScale and Urban A&O for the conceptual design in the Environmental and Sustainability category.

TerraScale’s Energos Reno project will include the development of a data center that will leverage renewable energy infrastructure. Energos Reno is a large-scale mixed-use development near Reno, Nevada that aims to enable secure storage and transmission of data between government agencies and commercial clients. TerraScale intends to develop a data center as well as further develop renewable energy infrastructure assets. The project site will also act as a pilot ground for new and emerging green technologies.

«Teaming with Urban A&O as part of our Energos Reno Project has been incredibly valuable as we pursue the largest commercial development in the United States powered by on-site renewable energy,» said Soheila Yalpani, COO of TerraScale.

«We are honored by this recognition together with Joe MacDonald’s team at Urban A&O,» said Danny Hayes, CEO of TerraScale.

«Being recognized by OPAL for our work on the conceptual design of TerraScale’s Energos Reno Project, is a tremendous honor,» said Joe MacDonald of Urban A&O. «We see architecture as an opportunistic interface for sustainability, technology and design and we’re pleased to have collaborated with TerraScale as a way to showcase the possibilities in doing so.»

About TerraScale
TerraScale is a clean infrastructure design and development firm that is transforming and modernizing digital infrastructures around the world. Through the company’s consortium, TerraScale takes a unique approach to future proofing our planet by collaborating with best-in-class green engineering, technology, real estate, energy and construction firms globally, to ensure maximum value delivery across the lifecycle of its projects. TerraScale’s projects and programs are designed to meet the needs of government and industry in the most responsible, secure and sustainable manner.

For more information on TerraScale, please visit: https://terrascale.org

About Urban A&O
Joe MacDonald is a founding principal of Urban A&O, a design firm based in New York City, specializing in parametric modeling and resilient, sustainable material research. He regularly incorporates his academic research into practice at the scales of building, landscape and urban design. His seminars explore naturally occurring organizational systems and their influence on built ecologies, new materials, and construction assembly innovations. Four operating principles describe the philosophy of the firm’s work: sustainable material exploration; the use of emerging technologies to design and fabricate form; multi-disciplinary collaboration; and the cultivation of social interaction and education through design within the public realm. The theme of architecture as an opportunistic interface for technology and space–simultaneously physical and social–is central to their investigations into future building materials and construction methods.

For more information on Urban A&O, please visit: https://www.urbanao.com/

About Outstanding Property Awards London
OPAL seeks the best Architecture, Interior Design and Property Development projects from around the world, celebrating and honoring diverse exceptional projects globally. We want to see your most Outstanding projects addressing creativity, innovation, social impact, and sustainability while creating a unique cross-industry platform that unites experts and talents.

For more information on OPAL, please visit: https://outstandingpropertyaward.com/

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/terrascale-wins-platinum-2020-outstanding-property-award-london-in-property-design-301233745.html

SOURCE TerraScale

Latino Voices for Boardroom Equity Furthers Diversity Efforts by Tracking California Companies With No Latino Board Representation

WASHINGTON, Feb. 23, 2021 /PRNewswire/ — The Latino Corporate Directors Association and <a target="_blank"…

WASHINGTON, Feb. 23, 2021 /PRNewswire/ — The Latino Corporate Directors Association and Latino Voices for Boardroom Equity, today released the Q4 2020 California Boardroom Equity Scorecard—a tool that gauges the impact of AB 979 by monitoring board composition by ethnicity and race. This information will allow Latinos and other underrepresented groups to measure the progress of their representation on California company boards.

In partnership with Equilar, LCDA tracked 607 new board appointments made by California public companies between July 1 to December 31, 2020. Latinos gained only 14 board seats filled between July 1 to December 31, 2020, while the large majority of seats, 434, went to White/Caucasian directors, 74 seats went to Asian/Pacific Islander directors, and 73 seats went to Black/African American directors.

«The California Boardroom Equity Scorecard & Tracker provides investors and shareholders with information on the board composition of California public corporationsidentifying which companies have Latinos on their board of directors,» said Roel Campos, Former SEC Commissioner and LCDA Chair. «A commitment to diversity and inclusion is incomplete without Latinos who are two in ten Americans and account for 25% of national GDP. Investors understand the business value and want corporate boards to better reflect their customers and employees.»

The Q4 2020 Scorecard reveals that many California boards still lack diversity. At the end of Q4 2020, the boards of nearly one-third, 31.2%, of California public corporations were all White. Latinos hold only 2.3% of these board seats and 84.6% of California public company boards lack a Latino director, despite the fact that 39% of California’s population is Latino.

«It is encouraging that there has been some progress, but I am concerned that one-third of California company boards still lack diversity. We in the California Legislature will continue to monitor appointments of directors from underrepresented communities under the requirements of AB 979 to better reflect California’s population and the Nation. We greatly appreciate LCDA’s quarterly updates provided by the California Boardroom Equity Scorecard and Tracker,» stated Assemblymember Chris Holden

«While I’m pleased that women are being appointed to California boards in greater numbers, there has not been enough progress for women of color. The large majority, 71.5%, of female appointments were White/Caucasian, 12% Asian/Pacific Islander, 12% Black/African American, but most alarmingly only 2.5% of women appointed to California boards were Latina, while we make up over 20% of the population. We have many qualified Latinas and women of color ready to serve on boards, who rise to the occasion. Plus, research tells us, it’s in the companies’ best interests to do better and be intentional in their search for diverse female candidates,» said California Legislative Women’s Caucus Chair, Assemblymember Cristina Garcia.

Latino Voices has written to request meetings with all California public companies that lack Latino directors. «The Latino Voices coalition serves as a resource to US public companies to connect them with ample board talent. We are encouraged by productive meetings to date and invite companies to engage with us,» said Esther Aguilera, LCDA President and CEO.

ABOUT LCDA:
The Latino Corporate Directors Association (LCDA) is a national organization promoting C-level and board diversity to maximize business success. LCDA serves as an advocate and resource to corporate boards, search firms, private equity, and institutional investors interested in gaining access to exceptional Latino board talent. Our program areas focus on growing the supply of high-caliber boardroom candidates and providing quality corporate governance programming for experienced and aspiring directors.

ABOUT Latino Voices for Boardroom Equity:
In September 2020, LCDA launched Latino Voices for Boardroom Equity, in partnership with a growing list of national Latinos organizations including the League of United Latin American Citizens (LULAC), UnidosUS, Mexican American Legal Defense and Educational Fund (MALDEF), the United States Hispanic Chamber of Commerce (USHCC), the Association of Latino Professionals for America (ALPFA), and the National Hispanic Media Coalition (NHMC). This initiative asserts diversity without the inclusion of Latinos is not acceptable. The objective of the Latino Voices initiative is to triple US Latino representation on public company boards by 2023 by targeting corporations with no US Latino representation and tracking progress through the publication of a quarterly scorecard.

Contact:
Monique Navarro (915) 790-7788
mnavarro@latinocorporatedirectors.org

 

Cision View original content:http://www.prnewswire.com/news-releases/latino-voices-for-boardroom-equity-furthers-diversity-efforts-by-tracking-california-companies-with-no-latino-board-representation-301233736.html

SOURCE Latino Corporate Directors Association

Papros: MRPRO™ Distributed Through RMI Has the Best Opportunities for Upstream Revenue for Conflict Resource Mineral Data Gathering

SAN JOSE, Calif., Feb. 23, 2021 /PRNewswire/ — Papros Inc, a leader in supply chain management asserted that the program MRPRO™ for conflict minerals distributed through the RMI (Responsible Minerals Initiative) has the most prospects for revenue provisions for upstream actors in the supply chain.
 
In several recent international conferences, what has been brought to limelight is the fact that the supply chain data gathering process needs to provide greater rewards and incentives for…

SAN JOSE, Calif., Feb. 23, 2021 /PRNewswire/ — Papros Inc, a leader in supply chain management asserted that the program MRPRO™ for conflict minerals distributed through the RMI (Responsible Minerals Initiative) has the most prospects for revenue provisions for upstream actors in the supply chain.
 
In several recent international conferences, what has been brought to limelight is the fact that the supply chain data gathering process needs to provide greater rewards and incentives for upstream actors in the supply chain that come between the mines and the smelters. In most cases, these are people who are adversely constrained in terms of resources and are working hard to bring integrity to the supply chain. Currently, most corporate data collection systems generate big revenues for solution providers but the upstream actors who do the heavy work see very little monetary benefits. However, MRPRO™ for conflict minerals offers excellent opportunities to mitigate this situation for the upstream actors. It is distributed through the RMI and has been from day one, distributed free for the end user. Combined with free data gathering that are freely available based on many cloud data systems, the platform provides an effective way for large corporates to do their annual reports for essentially little or no cost and thus use the revenues to support charities and other good works for the upstream actors.
 
Papros brings a robust process in the generation of conflict mineral reports. It is flexible enough to allow for CMRTs (Conflict Mineral Reporting Template) as well as the CRT (Cobalt reporting Template). In the near future the MRT (Mica Reporting Template) is also planned to be supported. It has been supporting the CMRT rollup process for more than ten years. In addition, Papros also supports activities at the IPC for standardizing the data format for the IPC 1755 that describes the conversion needed for the CMRT/CRT to standards-based XML data.
 
It is no wonder that Papros platform is known universally as being the «Best Conflict Minerals platform» that enables companies to continue to relentlessly ensure their supplies of certain minerals are not tainted in their origins. Currently, that latest version has been optimized even further for ease of implementation and operation by offering many alternatives for users.
 
About Papros Inc: Papros Inc. has been committed to providing Total Environmental Management solutions to US and International companies. «Optimizing the Greenback and the Green Environment» has been the slogan of Papros Inc. since its inception more than thirty-five years ago.

This release was issued through WebWire®. For more information, visit http://www.webwire.com .

Dr. N Nagaraj
Chief
Papros Inc
4082794271
shaka777@gmail.com

Cision View original content:http://www.prnewswire.com/news-releases/papros-mrpro-distributed-through-rmi-has-the-best-opportunities-for-upstream-revenue-for-conflict-resource-mineral-data-gathering-301233226.html

SOURCE Papros Inc

PartsEye™ 2020 Year End Review

TAUNTON, Mass., Feb. 23, 2021 /PRNewswire/ — SmartCo Services LLC is pleased to announce 2020 PartsEye™ accomplishments.

TAUNTON, Mass., Feb. 23, 2021 /PRNewswire/ — SmartCo Services LLC is pleased to announce 2020 PartsEye™ accomplishments.

PartsEye™ technology manages retailer daily parts ordering using predictive data analysis ensuring best in industry parts & accessory availability where it counts…at the retailer.

2020 was thankfully another successful and exciting year for PartsEye™ with quite a list of memorable accomplishments even during what was a year like no other.  Most notably, Hyundai Motor America chose PartsEye™ as the preferred inventory management system for their 800+ dealerships.  Adding Hyundai to SmartCo’s growing list of customers, both domestic and international, helped to achieve the following successes compared to 2019:

  • Managed over $1 billion of inventory representing a 28% increase
  • Processed over $3 billion of orders representing a 15% increase
  • Processed over 16 million order lines representing a 13% increase
  • Over 1200 new dealers began using PartsEye™ representing a 36% increase

2020 was also a milestone year for SmartCo as the 15-year anniversary was celebrated in May and the company’s 5000th client was activated in July.  The new PartsEye™ website was also launched to complete the already productive year.

Contact SmartCo to find out how PartsEye™ can help your dealership increase part number availability, improve «off the shelf» and retail order fill rates, reduce «lost sales» and provide significant time savings for parts personnel while improving customer satisfaction.

PartsEye is the Retail Inventory Management solutions leader in the transportation sector with over 5,000 retailer implementations across the globe.

For more information please contact:
SmartCo Services LLC
200 Myles Standish Blvd, Taunton, MA  02780
Toll Free USA & Canada:  877-880-0816 / Toll Free Mexico:  01 800 099 0598
info@partseye.com
 / v3.partseye.net / www.smartcoservices.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/partseye-2020-year-end-review-301233730.html

SOURCE SmartCo Services

UCASU outlines 2021 strategy for greater investment return in post-pandemic world

ATLANTA, Feb. 23, 2021 /PRNewswire/ — UC Asset LP (OTCQX: UCASU) releases today a «white paper» prepared by the company’s management team, reviewing the firm’s investment strategy in 2020 and outlining the 2021 strategy.

«This is the first time we are openly discussing our 2020 strategy,» says Greg Bankston, managing partner, UC Asset. «This document discloses how we systematically analyzed the market, why we have decided to scale back on new builds and slowly…

ATLANTA, Feb. 23, 2021 /PRNewswire/ — UC Asset LP (OTCQX: UCASU) releases today a «white paper» prepared by the company’s management team, reviewing the firm’s investment strategy in 2020 and outlining the 2021 strategy.

«This is the first time we are openly discussing our 2020 strategy,» says Greg Bankston, managing partner, UC Asset. «This document discloses how we systematically analyzed the market, why we have decided to scale back on new builds and slowly reduced our inventory. It illustrates how we have managed to increase our cash reserve, and what great opportunities we are preparing for in the coming months.» 

2020 was a unique year for real estate investors. The world was hit by the COVID pandemic and the economy of the States crippled. Commercial properties performed relatively poorly, and some categories of commercial properties took a big hit, due to the decrease of business and social activities. Meanwhile, residential properties experienced unusual value soaring.

UC Asset management believes the hike in residential property prices was an unexpected and unsustainable result of the pandemic. As early as July 2020, UC Asset management concluded that residents, after a long period of shielding-at-home, developed stronger desires to improve their living space, by either remodeling their existing homes or buying new. This desire of individual consumers led to a dramatic increase in demand for housing purchases, despite a shrunken economy and decreased employment.

A few months later, UC Asset’s observation and projection was echoed by industrial leaders such as Redfin, Realtor.com, and Zillow.com. «We are pleased our analysis, made several months earlier in the year were parallel with these industry leaders,» boasts Bankston.

Additionally, UC Asset concluded the fast rising of building costs compromised investors’ profit in building or renovating homes, despite the rising residential prices. This, ironically, would lead to less supply and tight inventory, and therefore push house price even higher. Based on this observation, in the summer of 2020, UC Asset adopted a forward-looking strategy. «We halted new builds, focused on completing existing projects, and held back sales of our inventory as we projected they could be sold later for better prices,» shares Bankston.

This forward-looking strategy helped UC Asset to stay profitable later in 2020, and to build up its cash reserve.

With significant amount of cash in hands, UC Asset is aiming its radar at the dynamics of commercial property market. «COVID-19 pandemic shook up the commercial market. It expediated some long-term changes which people would be less willing to make in a more stable environment. These changes will be disruptive, and even revolutionary. Some properties which suffered a loss during the pandemic will be worth two times, three times or even more in a post-pandemic world. And our job is to identify these properties,» says Larry Wu, founder of UC Asset.

Wu says the firm is excited about their new business strategy which is a direct response to market trends that may be more compelling in post-pandemic world. «For one thing, we are avidly pursuing our SHOC strategy. We believe that SHOC is a revolutionary model that will renovate communities and disrupt the conventional hotel business. We have seen great results with a few pilot projects prior to SHOC.  One such project achieved over a 50% annualized return on a single sale. With the innovative SHOC model, we will be able to deliver better returns for our investors.»

The entire White Paper can be viewed here: https://www.ucasset.com/WhitePapers/2021%20Management%20White%20Paper.pdf

About UC Asset:

UC Asset LP is a limited partnership formed for the purpose of investing in real estate for development and redevelopment, concentrating in metropolitan areas of Atlanta, GA. For more information about UC Asset, please visit: www.ucasset.com  

 

Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this News Release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.

 

For More Information Contact:  
Christal Jordan | Investor Relations Director, UC Asset LP
cjordan@ucasset.com | 678-499-0297

Cision View original content:http://www.prnewswire.com/news-releases/ucasu-outlines-2021-strategy-for-greater-investment-return-in-post-pandemic-world-301233724.html

SOURCE UC Asset LP

Grupos líderes defensores de la salud y la lucha contra el cáncer se unen para reducir las desigualdades raciales en la atención oncológica

NCCN, ACS CAN y NMQF   presentan nuevos resultados de encuestas que evidencian las percepciones frente a los prejuicios de pacientes, cuidadores y proveedores de atención, y sugieren cambios en políticas y prácticas para mejorar la equidad en el acceso a la atención de alta calidad para el tratamiento del cáncer.

WASHINGTON y PLYMOUTH MEETING, Pensilvania, 23 de febrero de 2021 /PRNewswire-HISPANIC PR WIRE/ — El día de hoy, National Comprehensive Cancer Network® (<a…

NCCN, ACS CAN y NMQF   presentan nuevos resultados de encuestas que evidencian las percepciones frente a los prejuicios de pacientes, cuidadores y proveedores de atención, y sugieren cambios en políticas y prácticas para mejorar la equidad en el acceso a la atención de alta calidad para el tratamiento del cáncer.

WASHINGTON y PLYMOUTH MEETING, Pensilvania, 23 de febrero de 2021 /PRNewswire-HISPANIC PR WIRE/ — El día de hoy, National Comprehensive Cancer Network® (NCCN®), American Cancer Society Cancer Action Network (ACS CAN) y National Minority Quality Forum (NMQF) presentaron nuevas ideas para superar la desigualdad en la oncología. Las recomendaciones, que fueron desarrolladas por un grupo de 17 expertos nacionales que representaban a pacientes y activistas, cuidadores, proveedores de atención en salud, investigadores y a la industria, abordan de manera directa la forma en que los sistemas médicos en los Estados Unidos a menudo fallan de forma desproporcionada a los pacientes que pertenecen a grupos minoritarios, en particular a los afroamericanos e indígenas. Además, los expertos se apoyan en datos estadísticos masivos de una encuesta reciente publicada por Public Opinion Strategies en nombre de las organizaciones para dejar en claro que el caso requiere acciones urgentes.

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

Algunos de los hallazgos más destacados de la encuesta son: entre los pacientes, sobrevivientes y cuidadores, el 63 % de afroamericanos y el 67 % de Latinxs mencionó haber tenido alguna experiencia negativa con su equipo de oncología, como que se hicieran supuestos sobre ellos o su situación financiera, o experimentaron dificultades para encontrar respuestas a sus preguntas. Esto contrasta con el 43 % de encuestados blancos que reportaron situaciones de ese tipo. En el caso de los profesionales de oncología, 2/3 de los encuestados consideraban que los pacientes no blancos experimentaron peores resultados en la atención del cáncer, y solo 1/3 consideró que esas poblaciones de pacientes estuvieran recibiendo una atención de menor calidad o una comunicación poco efectiva durante la atención.

«La investigación ha demostrado que las desigualdades en resultados no están basadas en la biología, sino que son el resultado de la desigualdad sistémica y la parcialización en el acceso y la prestación del servicio», afirmó el Dr. Robert W. Carlson, director ejecutivo de NCCN. «El racismo existe en los Estados Unidos e impacta en todas las esferas, incluyendo la comunidad médica. Un método probado que ayuda a mejorar la equidad es implementar la atención acorde a pautas. Estamos agradecidos por poder aprender de los expertos acerca de lo que podemos hacer ahora mismo para asegurar que todas las personas reciban la mejor atención con base en evidencias que sea posible. Este proceso ha sido a la vez instructivo e inspirador. Ahora estamos comprometidos a trabajar juntos para que estas recomendaciones se hagan realidad».

«Las comunidades de color y otros grupos médicamente marginados siguen presentando tasas más altas de cáncer y tienen menores probabilidades que las de otros grupos de obtener un diagnóstico temprano o de recibir un tratamiento óptimo», comentó Lisa Lacasse, presidenta de ACS CAN. «Asegurar que las prácticas clínicas de calidad estén vigentes y se implementen de manera equitativa a todos los pacientes independientemente de su raza, grupo étnico, nivel socioeconómico o ubicación geográfica es esencial para reducir estas desigualdades. Hasta que no reduzcamos la carga de esta enfermedad para todas las comunidades, no nos será posible lograr nuestra misión de lograr un mundo sin cáncer. Estas recomendaciones son un importante recurso para lograr ese objetivo».

«Podremos mejorar los resultados con respecto al cáncer para las comunidades de color y en áreas rurales al cerrar las brechas en evaluación, diagnóstico, tratamiento y supervivencia, tanto en la práctica clínica como a nivel político», indicó Gary A. Puckrein, PhD, presidente y director ejecutivo de NMQF. «NMQF se complace en colaborar con NCCN y ACS CAN para desarrollar recomendaciones basadas en evidencias que nos permitan diseñar un sistema que preste una atención oncológica de alta calidad a todas las diversas poblaciones de los Estados Unidos».

Para abordar las desigualdades en el acceso a la atención oncológica, las tres organizaciones convocaron el Elevating Cancer Equity Working Group (Grupo de trabajo para incrementar la equidad frente al cáncer), copresidido por Shonta Chambers, MSW, vicepresidenta ejecutiva de Iniciativas de Equidad en Salud y Compromiso Comunitario de Patient Advocate Foundation, y el Dr. Robert Winn, director de VCU Massey Cancer Center. Entre las recomendaciones del grupo de trabajo se incluye un nuevo Informe de Equidad para ayudar a los proveedores, contribuyentes y entidades de acreditación a avanzar hacia una prestación equitativa del servicio. Este informe incluye 17 cambios perceptibles en las prácticas, como asegurar que los sistemas de salud ofrezcan y requieran capacitación anual en parcialización implícita para todos los empleados, disponer orientadores del paciente o trabajadores de la salud cultural y lingüísticamente representativos a través de la contratación interna o la contratación con organizaciones de base comunitaria, y ofrecer horarios flexibles para las citas de evaluación y tratamiento. La lista completa de prácticas recomendadas está desglosada en las siguientes categorías:

  • Participación comunitaria
  • Acceso a la atención y determinantes sociales de la salud
  • Gestionar la parcialización en la prestación del servicio
  • Calidad e integralidad de la atención

Las recomendaciones se explicarán con mayor detalle durante un discurso de apertura en la Conferencia Anual NCCN 2021 Virtual que se sostendrá en modalidad online el 19 de marzo.

Asimismo, las organizaciones crearon una serie de recomendaciones para cambios de políticas dirigidas a:

  • El Congreso de los Estados Unidos
  • CMS y contribuyentes comerciales
  • Agencias federales
  • Legisladores a nivel estatal y local

Algunos ejemplos de políticas incluyen medidas para eliminar barreras a la participación en pruebas clínicas y requerir que la Administración de Alimentos y Medicamentos tenga en cuenta la diversidad en pruebas clínicas como parte del proceso de aprobación de medicamentos, ofrecer recursos a universidades y colegios universitarios históricamente afroamericanos y a otras instituciones que atienden grupos minoritarios con el objetivo de fomentar una fuerza laboral sanitaria más diversa, financiar campañas de difusión pública en torno a la prevención del cáncer que cultural y lingüísticamente reflejen las audiencias diversas, y asegurar el acceso a los orientadores de pacientes y su correspondiente reintegro para personas con todos los tipos de seguros.

Los grupos planean una serie de compromisos permanentes para los proveedores, pacientes y legisladores como recurso para avanzar en esta labor y mejorar la atención del paciente. En un artículo revisado por pares que se publicará próximamente, se presentará un análisis más profundo de los datos de Public Opinion Strategies. Esta información fue recabada en dos encuestas: una dirigida a pacientes, sobrevivientes y cuidadores familiares utilizando sobremuestreo para asegurar la representación de las minorías y la otra entre profesionales de la oncología.

Para obtener más información acerca del grupo de trabajo y próximos avances, visite NCCN.org/policy. Participe de la conversación virtual con la etiqueta #ElevatingCancerEquity.

Acerca de ACS CAN
American Cancer Society Cancer Action Network (ACS CAN) trabaja para situar al cáncer como prioridad central para los oficiales públicos y los candidatos en los niveles federal, estatal y local. ACS CAN empodera a defensores en todo el país para que sus voces sean escuchadas e influencien cambios en políticas públicas basados en evidencias, al igual que soluciones legislativas y regulatorias que reduzcan las cargas del cáncer. Como la filial activista, sin fines de lucro y no partidista de American Cancer Society, ACS CAN es una pieza clave en la lucha por un mundo sin cáncer. Para obtener más información, visite www.fightcancer.org.

Acerca de National Comprehensive Cancer Network
National Comprehensive Cancer Network® (NCCN®) es una alianza sin fines de lucro conformada por importantes centros oncológicos dedicada a la atención del paciente, la investigación y la educación. NCCN se dedica a mejorar y facilitar una atención oncológica de calidad, efectiva y accesible, para que los pacientes puedan tener una vida mejor. Visite NCCN.org para obtener más información sobre las pautas de la práctica clínica en oncología de NCCN (NCCN Guidelines®) y otras iniciativas. Siga a NCCN en Facebook @NCCNorg, Instagram @NCCNorg y Twitter @NCCN.

Acerca de National Minority Quality Forum
National Minority Quality Forum apoya a proveedores, profesionales, administradores, investigadores, legisladores y organizaciones comunitarias y basadas en la fé que prestan servicios de salud para que puedan proveer una atención apropiada a las comunidades minoritarias. Este apoyo se basa en el suministro de evidencias en forma de ciencia, investigación y análisis que conduzcan a una organización y gestión efectiva de los recursos del sistema con el fin de mejorar la calidad y seguridad de la atención en salud para toda la población de los Estados Unidos, incluidas las minorías. Para obtener más información, por favor, visite www.nmqf.org.

Contactos para los medios:
ACS CAN: Allison Miller,
allison.miller@cancer.org, 202-585-3241 
NCCN: Rachel Darwin,
darwin@nccn.org, 267-622-6624
NMQF: Kelly Ann Collins,
media@nmqf-pr.org, 202-413-1187

Logotipo: https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

FUENTE National Comprehensive Cancer Network

Grupos líderes defensores de la salud y la lucha contra el cáncer se unen para reducir las desigualdades raciales en la atención oncológica

NCCN, ACS CAN y NMQF   presentan nuevos resultados de encuestas que evidencian las percepciones frente a los prejuicios de pacientes, cuidadores y proveedores de atención, y sugieren cambios en políticas y prácticas para mejorar la equidad en el acceso a la atención de alta calidad para el tratamiento del cáncer.

WASHINGTON y PLYMOUTH MEETING, Pensilvania, 23 de febrero de 2021 /PRNewswire-HISPANIC PR WIRE/ — El día de hoy, National Comprehensive Cancer Network® (<a…

NCCN, ACS CAN y NMQF   presentan nuevos resultados de encuestas que evidencian las percepciones frente a los prejuicios de pacientes, cuidadores y proveedores de atención, y sugieren cambios en políticas y prácticas para mejorar la equidad en el acceso a la atención de alta calidad para el tratamiento del cáncer.

WASHINGTON y PLYMOUTH MEETING, Pensilvania, 23 de febrero de 2021 /PRNewswire-HISPANIC PR WIRE/ — El día de hoy, National Comprehensive Cancer Network® (NCCN®), American Cancer Society Cancer Action Network (ACS CAN) y National Minority Quality Forum (NMQF) presentaron nuevas ideas para superar la desigualdad en la oncología. Las recomendaciones, que fueron desarrolladas por un grupo de 17 expertos nacionales que representaban a pacientes y activistas, cuidadores, proveedores de atención en salud, investigadores y a la industria, abordan de manera directa la forma en que los sistemas médicos en los Estados Unidos a menudo fallan de forma desproporcionada a los pacientes que pertenecen a grupos minoritarios, en particular a los afroamericanos e indígenas. Además, los expertos se apoyan en datos estadísticos masivos de una encuesta reciente publicada por Public Opinion Strategies en nombre de las organizaciones para dejar en claro que el caso requiere acciones urgentes.

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

Algunos de los hallazgos más destacados de la encuesta son: entre los pacientes, sobrevivientes y cuidadores, el 63 % de afroamericanos y el 67 % de Latinxs mencionó haber tenido alguna experiencia negativa con su equipo de oncología, como que se hicieran supuestos sobre ellos o su situación financiera, o experimentaron dificultades para encontrar respuestas a sus preguntas. Esto contrasta con el 43 % de encuestados blancos que reportaron situaciones de ese tipo. En el caso de los profesionales de oncología, 2/3 de los encuestados consideraban que los pacientes no blancos experimentaron peores resultados en la atención del cáncer, y solo 1/3 consideró que esas poblaciones de pacientes estuvieran recibiendo una atención de menor calidad o una comunicación poco efectiva durante la atención.

«La investigación ha demostrado que las desigualdades en resultados no están basadas en la biología, sino que son el resultado de la desigualdad sistémica y la parcialización en el acceso y la prestación del servicio», afirmó el Dr. Robert W. Carlson, director ejecutivo de NCCN. «El racismo existe en los Estados Unidos e impacta en todas las esferas, incluyendo la comunidad médica. Un método probado que ayuda a mejorar la equidad es implementar la atención acorde a pautas. Estamos agradecidos por poder aprender de los expertos acerca de lo que podemos hacer ahora mismo para asegurar que todas las personas reciban la mejor atención con base en evidencias que sea posible. Este proceso ha sido a la vez instructivo e inspirador. Ahora estamos comprometidos a trabajar juntos para que estas recomendaciones se hagan realidad».

«Las comunidades de color y otros grupos médicamente marginados siguen presentando tasas más altas de cáncer y tienen menores probabilidades que las de otros grupos de obtener un diagnóstico temprano o de recibir un tratamiento óptimo», comentó Lisa Lacasse, presidenta de ACS CAN. «Asegurar que las prácticas clínicas de calidad estén vigentes y se implementen de manera equitativa a todos los pacientes independientemente de su raza, grupo étnico, nivel socioeconómico o ubicación geográfica es esencial para reducir estas desigualdades. Hasta que no reduzcamos la carga de esta enfermedad para todas las comunidades, no nos será posible lograr nuestra misión de lograr un mundo sin cáncer. Estas recomendaciones son un importante recurso para lograr ese objetivo».

«Podremos mejorar los resultados con respecto al cáncer para las comunidades de color y en áreas rurales al cerrar las brechas en evaluación, diagnóstico, tratamiento y supervivencia, tanto en la práctica clínica como a nivel político», indicó Gary A. Puckrein, PhD, presidente y director ejecutivo de NMQF. «NMQF se complace en colaborar con NCCN y ACS CAN para desarrollar recomendaciones basadas en evidencias que nos permitan diseñar un sistema que preste una atención oncológica de alta calidad a todas las diversas poblaciones de los Estados Unidos».

Para abordar las desigualdades en el acceso a la atención oncológica, las tres organizaciones convocaron el Elevating Cancer Equity Working Group (Grupo de trabajo para incrementar la equidad frente al cáncer), copresidido por Shonta Chambers, MSW, vicepresidenta ejecutiva de Iniciativas de Equidad en Salud y Compromiso Comunitario de Patient Advocate Foundation, y el Dr. Robert Winn, director de VCU Massey Cancer Center. Entre las recomendaciones del grupo de trabajo se incluye un nuevo Informe de Equidad para ayudar a los proveedores, contribuyentes y entidades de acreditación a avanzar hacia una prestación equitativa del servicio. Este informe incluye 17 cambios perceptibles en las prácticas, como asegurar que los sistemas de salud ofrezcan y requieran capacitación anual en parcialización implícita para todos los empleados, disponer orientadores del paciente o trabajadores de la salud cultural y lingüísticamente representativos a través de la contratación interna o la contratación con organizaciones de base comunitaria, y ofrecer horarios flexibles para las citas de evaluación y tratamiento. La lista completa de prácticas recomendadas está desglosada en las siguientes categorías:

  • Participación comunitaria
  • Acceso a la atención y determinantes sociales de la salud
  • Gestionar la parcialización en la prestación del servicio
  • Calidad e integralidad de la atención

Las recomendaciones se explicarán con mayor detalle durante un discurso de apertura en la Conferencia Anual NCCN 2021 Virtual que se sostendrá en modalidad online el 19 de marzo.

Asimismo, las organizaciones crearon una serie de recomendaciones para cambios de políticas dirigidas a:

  • El Congreso de los Estados Unidos
  • CMS y contribuyentes comerciales
  • Agencias federales
  • Legisladores a nivel estatal y local

Algunos ejemplos de políticas incluyen medidas para eliminar barreras a la participación en pruebas clínicas y requerir que la Administración de Alimentos y Medicamentos tenga en cuenta la diversidad en pruebas clínicas como parte del proceso de aprobación de medicamentos, ofrecer recursos a universidades y colegios universitarios históricamente afroamericanos y a otras instituciones que atienden grupos minoritarios con el objetivo de fomentar una fuerza laboral sanitaria más diversa, financiar campañas de difusión pública en torno a la prevención del cáncer que cultural y lingüísticamente reflejen las audiencias diversas, y asegurar el acceso a los orientadores de pacientes y su correspondiente reintegro para personas con todos los tipos de seguros.

Los grupos planean una serie de compromisos permanentes para los proveedores, pacientes y legisladores como recurso para avanzar en esta labor y mejorar la atención del paciente. En un artículo revisado por pares que se publicará próximamente, se presentará un análisis más profundo de los datos de Public Opinion Strategies. Esta información fue recabada en dos encuestas: una dirigida a pacientes, sobrevivientes y cuidadores familiares utilizando sobremuestreo para asegurar la representación de las minorías y la otra entre profesionales de la oncología.

Para obtener más información acerca del grupo de trabajo y próximos avances, visite NCCN.org/policy. Participe de la conversación virtual con la etiqueta #ElevatingCancerEquity.

Acerca de ACS CAN
American Cancer Society Cancer Action Network (ACS CAN) trabaja para situar al cáncer como prioridad central para los oficiales públicos y los candidatos en los niveles federal, estatal y local. ACS CAN empodera a defensores en todo el país para que sus voces sean escuchadas e influencien cambios en políticas públicas basados en evidencias, al igual que soluciones legislativas y regulatorias que reduzcan las cargas del cáncer. Como la filial activista, sin fines de lucro y no partidista de American Cancer Society, ACS CAN es una pieza clave en la lucha por un mundo sin cáncer. Para obtener más información, visite www.fightcancer.org.

Acerca de National Comprehensive Cancer Network
National Comprehensive Cancer Network® (NCCN®) es una alianza sin fines de lucro conformada por importantes centros oncológicos dedicada a la atención del paciente, la investigación y la educación. NCCN se dedica a mejorar y facilitar una atención oncológica de calidad, efectiva y accesible, para que los pacientes puedan tener una vida mejor. Visite NCCN.org para obtener más información sobre las pautas de la práctica clínica en oncología de NCCN (NCCN Guidelines®) y otras iniciativas. Siga a NCCN en Facebook @NCCNorg, Instagram @NCCNorg y Twitter @NCCN.

Acerca de National Minority Quality Forum
National Minority Quality Forum apoya a proveedores, profesionales, administradores, investigadores, legisladores y organizaciones comunitarias y basadas en la fé que prestan servicios de salud para que puedan proveer una atención apropiada a las comunidades minoritarias. Este apoyo se basa en el suministro de evidencias en forma de ciencia, investigación y análisis que conduzcan a una organización y gestión efectiva de los recursos del sistema con el fin de mejorar la calidad y seguridad de la atención en salud para toda la población de los Estados Unidos, incluidas las minorías. Para obtener más información, por favor, visite www.nmqf.org.

Contactos para los medios:
ACS CAN: Allison Miller,
allison.miller@cancer.org, 202-585-3241 
NCCN: Rachel Darwin,
darwin@nccn.org, 267-622-6624
NMQF: Kelly Ann Collins,
media@nmqf-pr.org, 202-413-1187

Logotipo: https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

FUENTE National Comprehensive Cancer Network

FASTER Act for Sesame Labeling Introduced in the House of Representatives

MCLEAN, Va., Feb. 23, 2021 /PRNewswire/ — Today, FARE, the world’s leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, announced the bipartisan introduction of the <a target="_blank"…

MCLEAN, Va., Feb. 23, 2021 /PRNewswire/ — Today, FARE, the world’s leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, announced the bipartisan introduction of the Food Allergy Safety, Treatment, Education and Research (FASTER) Act of 2021 (H.R. 1202) by the U.S. House of Representatives. The bill, which is FARE’s highest legislative priority, was introduced by Rep. Doris Matsui (D-California) and Rep. Patrick McHenry (R-North Carolina).

«Nearly 1.6 million Americans are allergic to sesame, and they and their loved ones live with constant anxiety that sesame may be in the food products they purchase,» said Lisa Gable, chief executive officer of FARE. «With today’s reintroduction, ushered forward by the strong leadership of Rep. Matsui and Rep. McHenry, a critical new labeling law to help those with life-threatening food allergies is one step closer to reality.» Added Gable, «Our goal was to reintroduce this legislation within the first 100 days of Congress, and to achieve this milestone within the first 50 days of the new legislative session is a true testament to the hard work and dedication of the thousands of food allergy advocates from across the country.»

The FASTER Act (H.R. 1202) would require that sesame be labeled as an allergen on packaged foods. Sesame would become the ninth food allergen for which the U.S. Food and Drug Administration (FDA) requires plain-language labeling. Sesame is often used when a label reads «natural flavors» or «natural spices,» adding another layer of difficulty when consumers review product labels at their local grocery store.

The bill would also require the Secretary of Health and Human Services (HHS) to issue a report on scientific opportunities in food allergy research that examines prevention, treatment, and new cures. In addition, the legislation establishes a risk-based scientific process and framework for establishing additional allergens covered by the Federal Food, Drug, and Cosmetic Act.

«For food allergy families across the nation, ordinary activities – like going to school, a birthday party, or camp – require a great deal of preparation and vigilance,» said Congresswoman Matsui. «Accurate food ingredient labels are crucial for these families to make decisions with potentially life-threatening consequences. However, current FDA labeling requirements do not include sesame, leaving more than 1.5 million Americans with a sesame allergy to fend for themselves. Thanks to an amazing outpouring of grassroots advocacy last Congress we had over 90 bipartisan cosponsors on the FASTER Act, and we are confident that support for labeling sesame will only grow in this new Congress. Food allergy families are truly resilient, and together we are working hard to make sure that this bill gets across the finish line.»

Congressman McHenry said, «Over 1.5 million people are allergic to sesame, yet there is no requirement to include the ingredient on product labels. The FASTER Act changes this, providing a much-needed update to allergen labeling laws to include sesame. Additionally, the bill requires the Secretary of Health and Human Services to regularly review promising food allergy treatments and research, enabling us to better treat the millions of Americans that suffer from these life-threatening allergies. I am proud to support this legislation and am grateful for the work FARE has done raising awareness for sesame allergies.»

The FASTER Act was first introduced in April 2019 (H.R. 2117). After unanimously passing in the U.S. House of Representatives on November 17, 2020, a similar bill, (S. 3451) unanimously passed in the U.S. Senate on December 9. However, the legislative session expired before the House could consider the Senate’s revised version of the bill. 

FARE will now begin meeting virtually with legislators to gain support for the bipartisan FASTER Act and will mobilize advocates to ask their representatives to sign on as cosponsors. The legislation will be front and center when FARE hosts its second annual advocacy event, Courage at Congress 2021: Advocate for a Cure, taking place virtually on March 8-10.

For more information on the importance of the FASTER Act, please visit foodallergy.org/faster.

About FARE
FARE (Food Allergy Research & Education) is the world’s leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research. Our mission is to improve the quality of life and the health of individuals with food allergies, and to provide them hope through the promise of new treatments. FARE is transforming the future of food allergy through innovative initiatives that will lead to increased awareness, new and improved treatments and prevention strategies, effective policies and legislation and novel approaches to managing the disease. To learn more about FARE, visit our Living Teal™ YouTube channel, or www.foodallergy.org.

Cision View original content:http://www.prnewswire.com/news-releases/faster-act-for-sesame-labeling-introduced-in-the-house-of-representatives-301233721.html

SOURCE Food Allergy Research & Education